Home  |  Contact

Cellosaurus HEK293-CAGA (CVCL_ZD63)

[Text version]

Cell line name HEK293-CAGA
Synonyms HEK293 (CAGA)12
Accession CVCL_ZD63
Resource Identification Initiative To cite this cell line use: HEK293-CAGA (RRID:CVCL_ZD63)
Comments Characteristics: Robustly responds to signaling by activin and TGF-beta class ligands and employed in an assay measuring inhibition of ligand activity (PubMed=23543431).
Characteristics: Luciferase gene expression is under the control of a promoter containing a Smad binding element (SBE) (CAGA(12)).
Transfected with: UniProtKB; P08659; Firefly luciferase.
Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
Transformant: NCBI_TaxID; 28285; Adenovirus 5.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0045 (HEK293)
Sex of cell Female
Age at sampling Fetus
Category Transformed cell line
Publications

PubMed=22052913; DOI=10.1074/jbc.M111.270801
Cash J.N., Angerman E.B., Kattamuri C., Nolan K., Zhao H., Sidis Y., Keutmann H.T., Thompson T.B.
Structure of myostatin.follistatin-like 3: N-terminal domains of follistatin-type molecules exhibit alternate modes of binding.
J. Biol. Chem. 287:1043-1053(2012)

PubMed=22593183; DOI=10.1210/me.2012-1061
Cash J.N., Angerman E.B., Keutmann H.T., Thompson T.B.
Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.
Mol. Endocrinol. 26:1167-1178(2012)

PubMed=23543431; DOI=10.1177/1087057113482585
Cash J.N., Angerman E.B., Kirby R.J., Merck L., Seibel W.L., Wortman M.D., Papoian R., Nelson S., Thompson T.B.
Development of a small-molecule screening method for inhibitors of cellular response to myostatin and activin A.
J. Biomol. Screen. 18:837-844(2013)

Entry history
Entry creation02-Jul-2020
Last entry update02-Jul-2020
Version number1